logo-loader
viewExxon Mobil Corporation

Oil giants Exxon and Chevron find market hard to please - PRE-MARKET

Also featured: American Airlines and Merc & Co Inc

Mobil petrol station
Exxon Mobil's results mildly underwhelmed

Integrated oil majors Exxon Mobile Corporation and Chevron Corporation went head-to-head before the bell, though neither scored a knock-out.

Exxon (NYSE:XOM) shares were off 1.8% in screen-based trading, after it missed earnings expectations.

Second quarter net income of US$3.35bn was equivalent to 78 US cents, and although this was up from 41 US cents a year earlier, the market had been expecting a number around 84 US cents.

Chevron (NYSE:CVX) fared a bit better, with its shares down 0.1%, after it returned to profit in the second quarter.

Net income of US$1.5bn was equivalent to 77 US cents a share, compared to a loss of US$1.5bn or 78 US cents a share.

Revenue rose to US$33bn from US$28bn.

Drugs developer Merck & Co Inc (NYSE:MRK) edged higher in pre-market trading after second quarter sales of US$9.9bn topped the consensus forecast of US$9.75bn.

Earnings per share on the company's preferred measure clocked in at US$1.01, and the company guided the market to expect the full-year outcome to be somewhere between US$3.76 and US$3.88; that gives a midpoint of US$3.82, which is about three cents below the consensus.

The company said a cyber-attack in late June would constrain full-year performance.

The attack disrupted the company's operations worldwide and it admitted it still does not know “the magnitude of the impact of the disruption”.

American Airlines Group Inc (NASDAQ:AAL) lost altitude in pre-market trading after its second quarter earnings, even though they topped expectations.

Adjusted earnings per share of US$1.92 were five US cents ahead of expectations and up 8% year-on-year.

Revenues rose 7.2% to US$11.11bn, a shade ahead of the consensus estimate of US$11.09bn.

Quick facts: Exxon Mobil Corporation

Price: 59.13 USD

NYSE:XOM
Market: NYSE
Market Cap: $250.36 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Co-Diagnostics expects to win a CE mark-validated...

Co-Diagnostics Inc (NASDAQ:CODX) CEO Dwight Egan tells Proactive the Utah-based company expects to achieve a CE mark validation on its coronavirus detection test from the European Union by as early as next week. Egan says the company is very enthused by the entire process of the development...

1 day, 9 hours ago

2 min read